BioSpace News Archive

Thiazide diuretics reduced the risk of fractures in people with Alzheimer’s disease

The use of thiazide diuretics was associated with a decreased risk of low energy fractures in people with Alzheimer’s disease, a new study from the University of Eastern Finland shows.

April 24, 2019
·
1 min read
Business

CDMO Yposkesi appoints new Director of Viral Vector Manufacturing Operations

With 15 years’ bioproduction and cell & gene therapy expertise, Morad El Gueddari will take charge of Yposkesi’s industrial-scale viral vector manufacturing

April 24, 2019
·
2 min read
Cytura Therapeutics to Develop a New Class of Drugs Targeting genomic instability in cancer

Cytura Therapeutics announces the successful closure of a Seed financing round.

April 24, 2019
·
3 min read
Yposkesi chairman Dr. Frederic Revah to speak on ‘Manufacturing and the CDMO Perspective’

Dr. Revah will join fellow industry panelists at the Cell and Gene Meeting on the Med in Barcelona to discuss strategies for gene therapy manufacturing, on April 23rd

April 24, 2019
·
2 min read
BioCapital

Pharma Regulatory and Pricing Updates; Sign Up for a Complimentary Inside Health Policy Trial

Sign up for a free trial subscription to Inside Health Policy, the online news service on health care policy from the regulatory reporting experts at Inside Washington Publishers.

April 24, 2019
·
4 min read
Drug Development

MorphoSys and Galapagos Announce Initiation of GECKO Phase 2 Study with MOR106 in Atopic Dermatitis Patients

MorphoSys AG, Galapagos NV and Novartis Pharma AG announced the initiation of GECKO, a phase 2 study testing a subcutaneous formulation of MOR106 in combination with topical corticosteroids in patients with moderate to severe atopic dermatitis.

April 24, 2019
·
6 min read
Policy

Government Files Criminal Charges Against Opioid Distributor and Two Former Executives

The government said the executives and the company failed to comply with its legal obligation to report thousands of suspicious orders of controlled substances to the DEA.

April 24, 2019
·
3 min read
·
Alex Keown
Drug Development

Researchers Provide More Evidence That a Blood Test Can Detect the Risk of Alzheimer’s

Researchers at Sweden’s Lund University reported that a blood test can reveal whether there is accelerating nerve cell damage in the brain.

April 24, 2019
·
3 min read
·
Alex Keown
Deals

MDxHealth (R): MDxHealth provides Q1 2019 business update

MDxHealth SA, a commercial-stage innovative molecular diagnostics company, provided a business update for the first quarter ended March 31, 2019.

April 24, 2019
·
4 min read
Business

Ellume Appoints CFO And CBO

Ellume Limited is pleased to announce the appointment of David Green as Chief Financial Officer and Company Secretary, and Mark Boyle Chief Business Officer of the Company.

April 24, 2019
·
2 min read